Emily Grisnik, PA
Medical · Leonardtown, MDNPI 1144679416
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (35.0%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 34 manufacturers reported payments, led by Organon at 54.8% of the total. 2025 is the largest year on record at $45,659, more than ten times the $1,929 reported in 2021. Among medical clinicians in MD with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 853 payments — averaging $73.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Organon$34K
- Johnson & Johnson$4K
- AbbVie$4K
- Regeneron Healthcare Solutions, Inc.$2K
- Dermavant Sciences, Inc.$2K
- Amgen$2K
- plus $14K from 28 others
What the payments were for
- Consulting fees$9,46815%
- Speaking & faculty fees$20,90034%
- Travel & lodging$9,76416%
- Food & beverage$21,80535%
- Education$4501%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Organon | 70 | $34,173 |
| Johnson & Johnson | 65 | $4,082 |
| AbbVie(2 entities) | 118 | $3,946 |
| Regeneron Healthcare Solutions, Inc. | 29 | $2,328 |
| Dermavant Sciences, Inc. | 59 | $2,064 |
| Amgen | 36 | $1,806 |
| LEO Pharma Inc. | 77 | $1,531 |
| Galderma Laboratories, L.p. | 57 | $1,515 |
| Incyte Corporation | 45 | $1,283 |
| UCB, Inc. | 21 | $1,157 |
| Pfizer | 45 | $1,133 |
| Sanofi | 43 | $1,107 |
| Botanix SB Inc | 14 | $1,105 |
| Lilly USA, LLC | 36 | $987 |
| E.r. Squibb & Sons, L.L.C. | 45 | $963 |
| Novartis | 25 | $934 |
| Journey Medical Corporation | 5 | $621 |
| Arcutis Biotherapeutics, Inc. | 11 | $342 |
| Sun Pharmaceutical Industries Inc. | 12 | $280 |
| Sanofi-aventis U.S. LLC | 4 | $218 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 9 | $170 |
| Medimetriks Pharmaceuticals, Inc. | 3 | $152 |
| Mayne Pharma Commercial LLC | 4 | $89 |
| VYNE Pharmaceuticals Inc. | 2 | $67 |
| Almirall LLC | 4 | $63 |
| Boehringer Ingelheim | 2 | $54 |
| EPI Health, LLC | 1 | $40 |
| Helsinn Therapeutics (U.S.), Inc. | 2 | $36 |
| Verrica Pharmaceuticals Inc. | 2 | $33 |
| Strata Skin Sciences, Inc. | 3 | $30 |
| Kyowa Kirin, Inc. | 1 | $24 |
| ANI Pharmaceuticals, Inc. | 1 | $21 |
| LNHC, Inc | 1 | $20 |
| Sebela Pharmaceuticals Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$62,386 in reported general payments places this provider in the 95th percentile of 543 medical providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira(Cf) PenAdalimumab | 15 | $135,758 |
| Dupixent PenDupilumab | 19 | $71,099 |
| JubliaEfinaconazole | 11 | $13,426 |
| Doxycycline Ir-DrDoxycycline Monohydrate | 23 | $9,979 |
| Tacrolimus | 29 | $2,581 |
| Clobetasol Propionate | 31 | $1,878 |
| Tretinoin | 19 | $1,086 |
| Ketoconazole | 58 | $860 |
| Doxycycline Monohydrate | 18 | $425 |
| Mupirocin | 35 | $394 |
| Mometasone Furoate | 19 | $352 |
| Clindamycin Phosphate | 14 | $329 |
| Triamcinolone Acetonide | 52 | $274 |
| Nystatin | 19 | $239 |
| Hydroxyzine Hcl | 28 | $208 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Ortho Dermatologics, A Division Of Bausch Health US, LLCJublia | $170 | $13,42611 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 543 medical providers in Maryland.
Other medical in Leonardtown
- Victoria TrottStevensville$94K
- Sarah SagorskyBaltimore$68K
- Jennifer HamiltonBel Air$52K
- Kristina TrunnellFrederick$51K
- Karen ScottAnnapolis$49K
- Nicholas WunderAberdeen$40K
- Sarah JamiesonFrederick$34K
- Jayme WilliamsCatonsville$21K
- Megan PayneLutherville$19K
- Heather RosarioAbingdon$18K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.